Clinical Trial Update: Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating chemotherapy with or without monoclonal antibody therapy in patients with refractory or relapsed acute myeloid leukemia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: Facet Biotech | Conditions: Leukemia | Phase 3 | Status: UNKNOWN